Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets... Show more
RVTY is expected to report earnings to rise 12.87% to $1.14 per share on August 04
Q2'25
Est.
$1.14
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.15
Q2'24
Beat
by $0.10
The last earnings report on April 28 showed earnings per share of $1.01, beating the estimate of 94 cents. With 144.91K shares outstanding, the current market capitalization sits at 12.76B.